.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202129

« Back to Dashboard
NDA 202129 describes ZETONNA, which is a drug marketed by Takeda Gmbh and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the ZETONNA profile page.

The generic ingredient in ZETONNA is ciclesonide. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ciclesonide profile page.

Summary for NDA: 202129

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents

Suppliers and Packaging for NDA: 202129

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL 202129 NDA Sunovion Pharmaceuticals Inc. 63402-737 63402-737-30 1 CANISTER in 1 CARTON (63402-737-30) > 30 AEROSOL, METERED in 1 CANISTER
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL 202129 NDA Sunovion Pharmaceuticals Inc. 63402-737 63402-737-60 1 CANISTER in 1 CARTON (63402-737-60) > 60 AEROSOL, METERED in 1 CANISTER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;NASALStrength0.037MG/INH
Approval Date:Jan 20, 2012TE:RLD:Yes
Patent:6,006,745Patent Expiration:Dec 28, 2016Product Flag?YSubstance Flag?Delist Request?
Patent:6,120,752Patent Expiration:May 13, 2018Product Flag?YSubstance Flag?Delist Request?
Patent:6,264,923Patent Expiration:May 13, 2018Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 202129

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129-001Jan 20, 20125,605,674► Subscribe
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129-001Jan 20, 20125,683,677► Subscribe
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129-001Jan 20, 20126,036,942► Subscribe
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129-001Jan 20, 20126,006,745► Subscribe
Takeda Gmbh
ZETONNA
ciclesonide
AEROSOL, METERED;NASAL202129-001Jan 20, 20125,775,321► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc